Rambaud Jerome, Guellec Isabelle, Guilbert Julia, Léger Pierre-Louis, Renolleau Sylvain
Paediatric Intensive Care Unit, Armand-Trousseau Hospital APHP (Paris Hospitals Public Assistance), UPMC (Pierre and Marie Curie University, Paris VI), Paris, France.
Indian J Crit Care Med. 2015 Sep;19(9):513-7. doi: 10.4103/0972-5229.164797.
Extracorporeal membrane oxygenation (ECMO) is used during pediatric resuscitation in case of refractory hypoxemia or septic shock under maximum therapy. Previous studies describe calcium homeostasis dysregulation. The aim of this study was to confirmed of calcium homeostasis dysregulation in neonates under ECMO and supposed news explanation.
From November 2012 to July 2013, we performed a prospective single center observational study. Eleven neonatal patients were included. Blood was obtained before and during ECMO (day 7, 14 and 21) for parathyroid hormone (PTH), protein adjusted serum calcium, ionized calcium, magnesium, and calcitriol levels. All surviving patients underwent a consultation up to 6 months after ECMO weaning.
During ECMO PTH was inadequately high with normal serum calcium on day 7 (PTH: 73.54 ± 40 ng/l; calcemia: 2.33 ± 0.21 mmol/l), day 14 (PTH: 57.63 ± 29.57 ng/l; calcemia: 2.44 ± 0.43 mmol/l) and day 21 (PTH: 54.93 ± 8.43 ng/l; calcemia: 2.13 ± 0.09 mmol/l). The absence of correlation between serum calcium and PTH levels seem to confirm the dysregulation of PTH - serum calcium metabolism during ECMO. Six months after ECMO weaning, we noticed hypercalcemia with normal PTH.
We confirmed the existence of severe disturbances of calcium homeostasis in neonates on ECMO and supposed the possible damage of calcium regulation. We did not succeed in finding clear explanations of these disturbances.
在儿科复苏过程中,当采用最大治疗方案仍出现难治性低氧血症或感染性休克时,会使用体外膜肺氧合(ECMO)。既往研究描述了钙稳态失调的情况。本研究的目的是证实接受ECMO治疗的新生儿存在钙稳态失调,并推测新的原因。
2012年11月至2013年7月,我们开展了一项前瞻性单中心观察性研究。纳入了11例新生儿患者。在ECMO治疗前及治疗期间(第7天、14天和21天)采集血液,检测甲状旁腺激素(PTH)、蛋白校正血清钙、离子钙、镁和骨化三醇水平。所有存活患者在ECMO撤机后6个月内接受了会诊。
在ECMO治疗期间,第7天(PTH:73.54±40 ng/l;血钙:2.3 ± 0.21 mmol/l)、第14天(PTH:57.63±29.57 ng/l;血钙:2.44±0.43 mmol/l)和第21天(PTH:54.93±8.43 ng/l;血钙:2.13±0.09 mmol/l)时,PTH水平异常升高而血清钙正常。血清钙与PTH水平之间缺乏相关性,这似乎证实了ECMO治疗期间PTH - 血清钙代谢失调。ECMO撤机6个月后,我们发现血钙升高而PTH正常。
我们证实了接受ECMO治疗的新生儿存在严重的钙稳态紊乱,并推测可能存在钙调节受损的情况。我们未能成功找到这些紊乱的明确原因。